Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including Population Health, Equity & Outcomes; Evidence-Based Oncology™; and The Center for Biosimilars®. She has been working on AJMC since 2014 and has been with AJMC’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
Value-Based Payment Success Hinges on a Holistic Strategy for Changes
Piecemeal solutions to implement value-based payment arrangements will not be able to effectively enact change. Authors in The New England Journal of Medicine argue that a range of complementary solutions need to be pursued simultaneously based on previously successful tactics on a smaller scale.
ACOs Had No Significant Impact on Spending for Patients With Cancer
Accountable care organizations (ACOs) have not had a significant impact on cancer care costs and utilization. While cancer care costs did decline from before the introduction of ACOs to after, there was no significant difference in spending decreases between ACO practices and non-ACO practices caring for patients with cancer.
The US Oncology Network Announces Highly Positive MIPS Results for 2017
Practices in the US Oncology Network received an average positive payment adjustment under the Merit-based Incentive Payment System (MIPS) of 1.90% for performance in 2017, and 99% of the Network’s physicians were in the top tier of performers. The maximum allowable adjustment is 2.02%. The adjustment based on a clinician’s performance in 2017 impacts the clinician's Medicare reimbursement for 2019.
Process for Requesting Medical Records Remains Burdensome
Although patients have the right of access to their protected health information, actual access remains limited. A new study, published in JAMA Network Open, has found that the processing of requesting medical records remains burdensome despite policy efforts.
Tisagenlecleucel's High Price Aligns With Its Benefit in Pediatric B-ALL, Study Finds
Tisagenlecleucel's high price is aligned with the benefit the chimeric antigen receptor T-cell therapy provides over a patient's life. Approximately 40% of patients treated are expected to be long-term survivors.
Predictability and Simplicity Needed to Help ACOs Take on Risk, Panelists Say at NAACOS
During the opening plenary and panel at the fall 2018 meeting of the National Association of ACOs (NAACOS), Adam Boehler, of the Center for Medicare and Medicaid Innovation, highlighted the fact that CMS has to provide predictability and simplicity to get more accountable care organizations to take on risk and succeed, but that those who are not "cutting it" should "get out of the way" for others.
Cancer Types Can Impact How Well Providers May Perform Under OCM
The type of cancer a provider treats can determine how well he or she performs under the Oncology Care Model (OCM), according to research from Avalere Health that was presented at the American Society of Clinical Oncology Quality Care Symposium.
FDA Approves Once-Weekly Dose of Kyprolis for R/R Multiple Myeloma
A once-weekly dose of carfilzomib (Kyprolis) in combination with dexamethasone has been approved to treat patients with relapsed or refractory (R/R) multiple myeloma. The approved regimen improved progression-free survival and had a better overall response rate than a twice-weekly regimen.
FDA Approves NGS-Based Test That Detects Very Low Levels of Cancer Cells in ALL or MM
A test that uses next-generation sequencing (NGS) has been approved to detect and monitor minimal residual disease in patients with multiple myeloma (MM) and B-cell acute lymphoblastic leukemia (ALL).
Antibiotics May Be Feasible Alternative to Appendectomy in Acute Appendicitis
Antibiotic treatment may be a feasible alternative to surgery for uncomplicated acute appendicitis, according to findings from a 5-year observational follow-up study that compared appendectomy with antibiotic treatment.
Review Finds Mixed Results for APMs and New Care Delivery Models in Cancer
With cancer costs rising and patients with cancer disproportionately facing financial toxicity, alternative payment and care delivery models are thought to help alleviate some of the cost burden. However, a review finds limited evidence available to evaluate the efficacy of alternative payment and care models in cancer care.
Physicians Are Pessimistic About Future of Healthcare, Highlight Extent of Social Determinants
A majority of US physicians have a pessimistic view about the future of medicine, believe value-based payments won't improve quality of care or reduce costs, and treat patients with social conditions that impact their health.
NAACOS-Funded Study: ACOs Saved the Government $541.7M in 2013-2015
A new report contradicts CMS’ claim that the Medicare Shared Savings Program increased Medicare spending by $344 million from 2013 to 2015. The new analysis finds that accountable care organizations (ACOs) actually reduced federal spending by $542 million after accounting for shared savings payments earned.
CareMore Finds Success Using Lyft to Transport Medicare Beneficiaries to Appointments
Research has shown nonemergency medical transportation can be essential for patients in rural areas, as well as the poor, elderly, and chronically ill. In a Health Affairs blog post, authors from CareMore Health show how the company has found success with Lyft after a pilot program it ran in 2016.
Preventing Transportation of Mutant Protein Can Inhibit Growth of Leukemic Cells
Researchers at Baylor College of Medicine have found that preventing a mutated protein from leaving the nucleus and traveling to the cytoplasm of the cell can help inhibit the growth of leukemic cells in acute myeloid leukemia.
Prescription Drug Coverage Improved Survival for Patients With MM
Patients with multiple myeloma (MM) who are enrolled in a Medicare Part D plan or other creditable prescription drug coverage have better survival than patients without prescription drug coverage. According to a study in Journal of Clinical Oncology, this improved survival seemed to be a result of patients having access to all treatment options.
Improved Access Not as Important as High-Quality Care in Preventing Deaths Globally
Access to care is not enough to improve care and prevent deaths; expansion of health coverage has to be paired with investments to create high-quality health systems, according to a study in The Lancet.
Security Check Trays Pose Highest Risk of Spreading Respiratory Viruses in Airports
Airports provide multiple sites of risk to contract respiratory viruses, with plastic security screening trays posing the highest potential risk, according to new research published in BMC Infectious Diseases.